What do systematic reviews say?

Combination therapy vs placebo

The review found no eligible studies for this question.

• Anticholinergics combined with alpha‐blockers for treating lower urinary tract symptoms related to benign prostatic… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Combination therapy vs alpha‐blocker

• Anticholinergics combined with alpha‐blockers for treating lower urinary tract symptoms related to benign prostatic… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  19 studies · 3631 participants
  Very low

Combination therapy vs alpha‐blocker

• Anticholinergics combined with alpha‐blockers for treating lower urinary tract symptoms related to benign prostatic… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  15 studies · 2687 participants
  Very low

Combination therapy vs alpha‐blocker

Combination therapy showed no clear difference in adverse events compared with alpha‐blockers (low certainty).

• Anticholinergics combined with alpha‐blockers for treating lower urinary tract symptoms related to benign prostatic… 2021 · Cochrane Headline outcomes only
  RR 1.1 [0.9, 1.34]
  12 studies · 3561 participants
  Low

Combination therapy vs alpha‐blocker

Combination therapy showed no clear difference in AUR compared with alpha‐blockers (low certainty).

• Anticholinergics combined with alpha‐blockers for treating lower urinary tract symptoms related to benign prostatic… 2021 · Cochrane Headline outcomes only
  RR 2.03 [0.97, 4.23]
  19 studies · 4669 participants
  Low

Intervention not reported

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  19 studies · 1847 participants
  GRADE not reported

Intervention not reported

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  Low

Intervention not reported

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  Low

Intervention not reported

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  Low

Intervention not reported

The review found no eligible studies for this question.

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

The review found no eligible studies for this question.

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

The review found no eligible studies for this question.

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  10 studies · 799 participants
  GRADE not reported

Intervention not reported

It is very uncertain whether the intervention changes PUL (UroLift) (mixed estimate) (very low certainty).

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  RR 2.39 [0.51, 11.1]
  Studies not reported
  Very low

Intervention not reported

It is very uncertain whether the intervention changes PAE (mixed estimate) (very low certainty).

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  RR 4.39 [1.25, 15.44]
  Studies not reported
  Very low

Intervention not reported

The intervention may leads to higher TUMT (mixed estimate) (low certainty).

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  RR 9.71 [2.35, 40.13]
  Studies not reported
  Low

Intervention not reported

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  Low

Intervention not reported

It is very uncertain whether the intervention changes CRFWVT (Rezūm) (pairwise) (very low certainty).

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  RR 1.36
  Studies not reported
  Very low

Intervention not reported

It is very uncertain whether the intervention changes TIND (pairwise) (very low certainty).

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  RR 0.67
  Studies not reported
  Very low

Intervention not reported

• Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network… 2021 · Cochrane Headline outcomes only
  no estimate extracted
  6 studies · 640 participants
  GRADE not reported